Investor Presentation • Aug 31, 2022
Investor Presentation
Open in ViewerOpens in native device viewer
Q2'22 Presentation 31st of August 2022
This presentation is the managements summary of the 2nd quarter report, it includes forward-looking statements that reflect the Company's current views with respect to future events and financial and operational performance. These forward-looking statements may be identified by the use of forward-looking terminology.
These forward-looking statements are not historic facts. The forward-looking statements are not guarantees of future performance. The Company's actual financial position, operating results and liquidity, and the development of the industry in which the Company operates, may differ materially from those made in, or suggested, by the forward-looking statements.
The Company cannot guarantee that the intentions, beliefs, or current expectations upon which its forward-looking statements are based will occur.
By their nature, forward-looking statements involve, and are subject to, known and unknown risks, uncertainties, and assumptions as they relate to events and depend on circumstances that may or may not occur in the future. Because of these known and unknown risks, uncertainties and assumptions, the outcome may differ materially from those set out in the forward-looking statements.
These forward-looking statements speak only as at the date on which they are made. The Company undertakes no obligation to publicly update or publicly revise any forward-looking statement, whether as a result of new information, future events or otherwise. All subsequent written and oral forward-looking statements attributable to the Company or to persons acting on the Company's behalf are expressly qualified in their entirety by the cautionary statements referred to above and contained elsewhere in this presentation.
| 1 | Highlights for the period |
|---|---|
| 2 | Operational performance & Group financials |
| 3 | Key features |
| 4 | Growth projects |
| 5 | Outlook and summary |
The overall 2022 output structure maintained, with 2 new areas, as previously planned and future harvesting volume targets secured.
Operational EBIT pr. Kg (Farming)
▪ Arctic Fish has harvested 5.250 tonnes YTD, which is 7% less than at the same period last year.
High salmon prices in the quarter impact the operational EBIT pr. kg firmly
Price achievement increased by 29.7 NOK pr. kg
Production cost increased by 2.6 NOK pr. kg
Arctic Fish expects to stabilize and decrease production cost through:
| Key figures from P/L | ||||||
|---|---|---|---|---|---|---|
| KEY FIGURES | Q2 | Q2 | YTD | YTD | ||
| (NOK '000) | 2022 | 2021 | 2022 | 2021 | ||
| Operating revenues | 87.001 | 99.798 | 369.526 | 268.641 | ||
| Operational EBIT | 35.832 | 14.710 | -9.155 | 32.510 | ||
| Fair value adjustments | 36.913 | 42.748 | 61.163 | 83.021 | ||
| Production tax | -897 | -602 | -4.432 | -2.236 | ||
| EBIT | 71.849 | 56.856 | 47.576 | 113.295 | ||
| Net financial items | -24.951 | -9.855 | -16.033 | 7.427 | ||
| Earnings before tax (EBT) | 46.898 | 47.001 | 31.543 | 120.722 | ||
| Volume harvested GW | 1.029 | 1.824 | 5.250 | 5.617 | ||
| Operational EBIT pr.kg (farming) | 36,84 | 9,66 | 23,64 | 6,97 |
| (NOK '000) | 30.06.2022 | 31.03.2022 | 30.06.2021 |
|---|---|---|---|
| Reported long-term interest-bearing debt | 359.477 | 308.021 | 221.242 |
| Reported short-term interest-bearing debt | 40.406 | 37.914 | 40.125 |
| Reported bank deposits | -63.369 | -133.926 | -82.701 |
| Total net interest bearing debt | 336.514 | 212.008 | 178.666 |
| (NOK '000) | 30.06.2022 | 31.03.2022 | 30.06.2021 |
|---|---|---|---|
| Reported equity | 1.000.742 | 963.223 | 943.668 |
| Reported total assets | 1.539.719 | 1.449.293 | 1.311.356 |
| Equity ratio | 65,0 % | 66,5 % | 72,0 % |
| (NOK '000) | 30.06.2022 | 31.03.2022 | Loan agreement |
Unused 30.06.2022 |
|---|---|---|---|---|
| Total interest bearing debt | 399.883 | 345.935 | 771.432 | 371.549 |
▪ Net interest-bearing debt (NIBD) up by 125 MNOK in the quarter. The increase is due to working capital changes.
Harvesting facility building in Bolungarvík
▪ 175 MNOK harvesting plant facility
| 1 | Highlights for the period |
|---|---|
| 2 | Operational performance & Group financials |
| 3 | Key features |
| 4 | Growth projects |
| 5 | Outlook and summary |
First of its kind hi-tech smolt facility with 100% green energy1
All Icelandic attributes preserved; low sea temperature and density
No antibiotics have ever been used on Arctic Fish sites
| 1 | Highlights for the period | ||||
|---|---|---|---|---|---|
| 2 | Operational performance & Group financials | ||||
| 3 | Key features | ||||
| 4 | Growth projects | ||||
| 5 | Outlook and summary |
Current progress in Norður Botn
Design
Low biological risk for production areas ✓
Proximity to sea cargo solutions and excellent logistics ✓
Area for VAP, freezing and box factory available ✓
Developed labor market and supply industry ✓
Rendering of interior design
| 1 | Highlights for the period |
|---|---|
| 2 | Operational performance & Group financials |
| 3 | Key features |
| 4 | Growth projects |
| 5 | Outlook and summary |
▪ Arctic Fish continues developing according to its growth plan but harvesting quantities in 2022 take a substantial hit due to the mortality incident which occurred in Q1'2022. Harvesting volumes in 2022 are expected to be 8%
lower than in 2021 overall.
▪ In Q2'2022, the Company harvested 1.0 thousand tonnes (HOG) compared to 1.8 thousand tonnes for the same period the year before (2021) which is a 44% decrease.
| Q2 | Q2 | YTD | YTD | FY | |
|---|---|---|---|---|---|
| (NOK '000) | 2022 | 2021 | 2022 | 2021 | 2021 |
| Operating revenues | 87.001 | 99.798 | 369.526 | 268.641 | 595.895 |
| Cost of goods sold | -15.794 | 35.429 | 158.897 | 139.941 | 299.189 |
| Salaries | 16.432 | 13.352 | 33.595 | 25.371 | 54.151 |
| Depreciation | 13.355 | 11.211 | 25.849 | 21.601 | 46.501 |
| Other operating costs | 37.177 | 25.095 | 160.340 | 49.219 | 109.110 |
| Operational EBIT | 35.832 | 14.710 | -9.155 | 32.510 | 86.944 |
| Fair value adjustments | 36.913 | 42.748 | 61.163 | 83.021 | 44.897 |
| Production tax | -897 | -602 | -4.432 | -2.236 | -3.843 |
| EBIT | 71.849 | 56.856 | 47.576 | 113.295 | 127.998 |
| Other net financial items | -24.951 | -9.855 | -16.033 | 7.427 | 2.580 |
| Earnings before tax (EBT) | 46.898 | 47.001 | 31.543 | 120.722 | 130.578 |
| Taxes | -9.380 | 0 | -6.309 | 0 | 21.985 |
| Profit after tax from continuing operations | 37.518 | 47.001 | 25.234 | 120.722 | 152.563 |
| Profit after tax on discontinued operations incl. profit from sale | |||||
| Net profit/loss | 37.518 | 47.001 | 25.234 | 120.722 | 152.563 |
| Profit attributable to: | |||||
| Parent company shareholders | 37.518 | 47.001 | 25.234 | 120.722 | 152.563 |
| Minority interests | 0 | 0 | 0 | 0 | 0 |
| Earnings per share (NOK) | 1,18 | 1,47 | 0,79 | 3,79 | 4,79 |
| Earnings per share - diluted |
1,18 | 1,47 | 0,79 | 3,79 | 4,79 |
| (NOK '000) | 30.6.2022 | 31.3.2022 | 30.6.2021 | 31.12.2021 |
|---|---|---|---|---|
| Deferred tax assets | 13.170 | 22.550 | 0 | 19.479 |
| Intangible assets | 54.257 | 53.136 | 48.243 | 52.119 |
| Property, plant and equipment | 823.518 | 741.014 | 605.706 | 657.161 |
| Right of use assets | 4.098 | 4.234 | 0 | 4.435 |
| Non-current financial assets | 650 | 629 | 629 | 629 |
| Non-current assets | 895.693 | 821.563 | 654.579 | 733.823 |
| Biological assets | 439.584 | 335.904 | 469.846 | 512.010 |
| Other inventory | 23.881 | 28.725 | 30.900 | 33.785 |
| Receivables | 117.191 | 129.175 | 73.331 | 115.951 |
| Bank deposits | 63.369 | 133.926 | 82.701 | 38.126 |
| Current assets | 644.026 | 627.730 | 656.777 | 699.871 |
| TOTAL ASSETS | 1.539.719 | 1.449.293 | 1.311.356 | 1.433.695 |
| Share capital | 31.877 | 31.877 | 31.877 | 31.877 |
| Other equity | 968.865 | 931.347 | 911.791 | 943.631 |
| Equity | 1.000.742 | 963.223 | 943.668 | 975.508 |
| Deferred tax | 0 | 0 | 2.506 | 0 |
| Provisions | 0 | 0 | 2.506 | 0 |
| Long-term interest-bearing debt | 359.477 | 308.021 | 221.242 | 318.152 |
| Long term leasing liabilities | 3.420 | 3.254 | 0 | 3.424 |
| Total non-current liabilities | 362.897 | 311.275 | 221.242 | 321.576 |
| Short-term interest-bearing debt | 40.406 | 37.914 | 40.125 | 36.063 |
| Short term leasing liabilities | 1.252 | 1.165 | 0 | 1.138 |
| Trade payables | 119.224 | 123.479 | 93.003 | 91.052 |
| Other current liabilities | 15.198 | 12.237 | 10.812 | 8.357 |
| Current liabilities | 176.080 | 174.795 | 143.941 | 136.609 |
| TOTAL EQUITY AND LIABILITIES | 1.539.719 | 1.449.293 | 1.311.356 | 1.433.695 |
| Equity allocated to | ||||
|---|---|---|---|---|
| parent company | ||||
| 30.6.2022 | shareholders | |||
| (NOK '000) | Share capital | Share premium | Accumulated earnings | Total equity |
| Equity at 01.01.2022 | 31.877 | 1.001.740 | -58.109 | 975.508 |
| Total comprehensive income | 0 | 0 | 25.234 | 25.234 |
| Transactions with shareholders | ||||
| Dividend | 0 | 0 | 0 | 0 |
| Total transactions with shareholders | 0 | 0 | 0 | 0 |
| Equity at 30.06.2022 | 31.877 | 1.001.740 | -32.876 | 1.000.741 |
| 30.6.2021 | Equity allocated to parent company shareholders |
|||
| (NOK '000) | Share capital | Share premium | Accumulated earnings | Total equity |
| Equity at 01.01.2021 | 689.476 | 0 | -210.672 | 478.805 |
| Total comprehensive income | 0 | 0 | 120.722 | 120.722 |
| Transactions with shareholders | ||||
| Reclassification due to new parent | -689.476 | 12.888 | 0 | -676.588 |
| Proceeds from issue of new share capital | 26.158 | 650.431 | 0 | 676.588 |
| Proceeds from issue of new share capital | 5.719 | 344.281 | 0 | 350.000 |
| Transaction costs | 0 | -5.859 | 0 | -5.859 |
| Total transactions with shareholders | -657.600 | 1.001.740 | 0 | 344.141 |
| Equity at 30.06.2021 | 31.877 | 1.001.740 | -89.950 | 943.667 |
| Q2 | Q2 | YTD | YTD | FY | |
|---|---|---|---|---|---|
| (NOK '000) | 2022 | 2021 | 2022 | 2021 | 2021 |
| Operational EBIT | 35.833 | 14.710 | -9.155 | 32.510 | 86.944 |
| Adjusted for: | |||||
| Depreciation | 13.355 | 11.211 | 25.849 | 21.601 | 46.501 |
| Production tax | -897 | -602 | -4.432 | -2.236 | -3.843 |
| Change in inventories/biological assets | -61.924 | -36.769 | 143.492 | 11.512 | -71.661 |
| Change in account receivables and accounts payables | 7.728 | -4.876 | 26.931 | -46.503 | -91.074 |
| Change in other current assets and liabilities | 2.961 | 2.869 | 6.841 | 1.317 | -1.138 |
| Net cash flow from operating activities | -2.943 | -13.457 | 189.526 | 18.201 | -34.271 |
| Cash flow from investing activities | |||||
| Payments for purchase of fixed assets and licenses (MAB) |
-96.865 | -43.738 | -194.028 | -81.269 | -160.846 |
| Net cash flow from investing activities | -96.865 | -43.738 | -194.028 | -81.269 | -160.846 |
| Cash flow from financing activities | |||||
| Proceeds from borrowings | 31.591 | 0 | 54.559 | 0 | 119.797 |
| Repayment of borrowings | -15 | -19.579 | -18.958 | -49.916 | -39.425 |
| Installments on right to use liabilities | -360 | 0 | -503 | 0 | -528 |
| Interest payments for right to use liabilities | -50 | 0 | -100 | 0 | -153 |
| Current debt change | 2.715 | -182.546 | 4.566 | -216.624 | -247.450 |
| Issued new share capital | 0 | 0 | 0 | 344.141 | 344.140 |
| Net interest payments | -4.630 | -5.670 | -9.819 | -11.003 | -22.311 |
| Net cash flow from financing activities | 29.251 | -207.795 | 29.745 | 66.598 | 154.070 |
| Net increase in bank deposits | -70.557 | -264.990 | 25.243 | 3.530 | -41.046 |
| Bank deposits as of start of period |
133.926 | 347.691 | 38.126 | 79.171 | 79.171 |
| Bank deposits at the end of the period | 63.369 | 82.701 | 63.369 | 82.700 | 38.126 |
| Rank | Name | # of shares | % ownership |
|---|---|---|---|
| 1 | NORWAY ROYAL SALMON ASA | 16.346.824 | 51,28% |
| 2 | Sildarvinnslan hf ** | 10.899.684 | 34,19% |
| 2 | J.P. Morgan Bank Luxembourg S.A. ** | 1.301.149 | 4,08% |
| 3 | Landsbankinn hf. | 479.651 | 1,50% |
| 4 | KVERVA FINANS AS | 258.000 | 0,81% |
| 5 | VERDIPAPIRFONDET NORDEA AVKASTNING | 237.107 | 0,74% |
| 6 | CLEARSTREAM BANKING S.A. | 203.751 | 0,64% |
| 7 | VERDIPAPIRFONDET PARETO INVESTMENT | 190.000 | 0,60% |
| 8 | VERDIPAPIRFONDET EIKA SPAR | 172.312 | 0,54% |
| 9 | GÅSØ NÆRINGSUTVIKLING AS | 166.700 | 0,52% |
| 10 | MP PENSJON PK | 165.000 | 0,52% |
| 11 | PACTUM AS | 152.751 | 0,48% |
| 12 | VERDIPAPIRFONDET EIKA NORGE | 125.225 | 0,39% |
| 13 | VERDIPAPIRFONDET NORDEA KAPITAL | 113.504 | 0,36% |
| 14 | Íslandsbanki hf. | 111.513 | 0,35% |
| 15 | State Street Bank and Trust Comp | 98.616 | 0,31% |
| 16 | J.P. Morgan Bank Luxembourg S.A. | 83.849 | 0,26% |
| 17 | VERDIPAPIRFONDET NORDEA NORGE PLUS | 82.702 | 0,26% |
| 18 | ROTH | 80.000 | 0,25% |
| 19 | Euroclear Bank S.A./N.V. | 46.989 | 0,15% |
| 20 | SKEIE ALPHA INVEST AS | 46.000 | 0,14% |
| Ownership of 20 largest shareholders | 31.361.327 | 98,38% | |
| Total number of shares | 31.876.653 | 100,00% |
*20 largest shareholders list includes nominee accounts that are composed of multiple individual shareholders.
**Sildarvinnslan hf is a part of the nominee account "J.P. Morgan Bank Luxembourg S.A." but is shown seperately
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.